Previous 10 | Next 10 |
Ad hoc announcement pursuant to Art. 53 LR SGI debt facility to provide Spexis up to half of the projected ColiFin ® Phase 3 development costs, including those involving both COPILOT and COPA SGI has invested in Spexis as part of the ColiFin ...
Ad hoc announcement pursuant to Art. 53 LR Inhaled murepavadin shown to be well tolerated at all dose levels Program derived from Spexis’ macrocycle platform Data support moving forward to Phase 2 in cystic fibrosis and non-cystic fibrosis bronchiect...
AIkido Pharma Appoints Dr. Scott T. Tagawa, M.D. to Scientific Advisory Board PR Newswire NEW YORK , Feb. 3, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that Dr. Scott T. Tagawa , M.D., M.S., FACP, a Prof...
Aikido Pharma Secures Early Interest in Next Generation Radiotherapy Currently in Human Phase 2 Trials for Treatment of Prostate Cancer PR Newswire NEW YORK , Feb. 1, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today ann...
NEW YORK , March 10, 2020 /PRNewswire/ -- Spherix Incorporated (SPEX) ("Spherix" or the "Company"), a technology development company committed to the fostering of innovative ideas, announced today the closing of its previously announced registered direct offering with several in...
NEW YORK , March 10, 2020 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today provided an update on the recently announced treatment for Coronavirus technology optioned by the Company. As noted in patent number 10,434,116 "Methods of Treating Coronavirus Infection...
Gainers: Safe-T Group (NASDAQ: SFET ) +58% . More news on: Safe-T Group Ltd, Enable Midstream Partners, LP, Cypress Semiconductor Corporation, Stocks on the move, , Read more ...
Stitch Fix (NASDAQ: SFIX ) -29% on Q4 revenue growth . More news on: Stitch Fix, Inc., TRACON Pharmaceuticals, Inc., Spherix Incorporated, Stocks on the move, , Read more ...
NEW YORK , March 9, 2020 /PRNewswire/ -- Spherix Incorporated (SPEX) ("Spherix" or the "Company"), a technology development company committed to the fostering of innovative ideas, today announced that it has entered into definitive agreements with several institutional and accredited inve...
Gainers: Spherix (NASDAQ: SPEX ) +146% . More news on: Spherix Incorporated, AIM ImmunoTech Inc., LightPath Technologies, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
AIkido Pharma Company Name:
SPEX Stock Symbol:
NASDAQ Market:
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle therapeutics for rare diseases and oncology, today announced that Hernan Levett, currently Chief Fin...
ALLSCHWIL, Switzerland, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle therapeutics for rare diseases and oncology, announced today that it will host a business update conference call on October 9, 2023, at 8.30am EDT. ...
Ad hoc announcement pursuant to Art. 53 LR Balixafortide, a potent CXCR4 inhibitor, to be evaluated for the treatment of pancreatic ductal adenocarcinoma (PDAC) Spexis closed capital commitments totaling USD $7.5 million supporting Phase 3 ColiFin ® program in cystic fi...